Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities

Journal of Cell Biology

Volumn 136, Issue 4, 1997, Pages 775-788

  Meyer, Kay N ^a   Kjeldsen, Eigil ^b   Straub, Tobias ^a   Knudsen, Birgitta R ^b   Hickson, Ian D ^c   Kikuchi, Akihiko ^d   Kreipe, Hans ^a   Boege, Fritz ^a,b,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NAGOYA UNIVERSITY   (Japan)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; ISOENZYME;

ARTICLE; CATALYSIS; CELL CYCLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL;

EID: 0031018820     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.136.4.775     Document Type: Article

References (69)

1. Adachi, Y., M. Luke, and U.K. Laemmli. 1991. Chromosome assembly in vitro: lopoisomerase II is required for condensation. Cell. 64:137-48.
2. Baker, S.D., R.M. Wadkins, C.F. Stewart, W.T. Beck, and M.K. Danks. 1995. Cell cycle analysis of amount and distribution of nuclear DNA Topoisomerase I as determined by fluorescence digital imaging microscopy. Cytometry. 19:134-145.
3. Bharti, A., M. Olson, D. Kufe, and E. Rubin. 1996. Identification of a nucleolin binding site in human tupoisomerase I. J. Biol. Chem. 271:1993-1997.
4. Biersack, H., S. Jensen, I. Gromova, I. Nielsen, O. Westergaard, and A. Andersen. 1996. Active heterodimers are formed from human DNA topoisomerases IIalpha and beta isofoms. Proc. Natl. Acad. Sci. USA. 93:8288-8293.
5. Boege, F., E. Kjeldsen, F. Gieseler, J. Alsner, and H. Biersack. 1993. A drug-resistant variant of topoisomerase IIalpha in human HL-60 cells exhibits alterations in catalytic pH optimum. DNA-binding and sub-nuclear distribution. Eur. J. Biochem. 218:575-584.
6. Boege, F., A. Andersen, S. Jensen, R. Zeidler, and H. Kreipe. 1995. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase IIalpha. Delineation of a carboxyterminal epitope with peptide antibodies. Am. J. Pathol. 146:1302-1308.
7. Boege, F., T. Straub, A. Kehr, C. Boesenberg, K. Christiansen, A. Andersen, F. Jakob, and J. Köhrle. 1996. Selected novel flavones inhibit the DNA-binding or the DNA-religation step of eukaryotic topoisomerase I. J.Biol. Chem. 271:2262-2270.
8. Bonven, B.J., E. Gocke, and O. Westergaard. 1985. A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin. Cell. 41:541-551.
9. Cardenas, M., and S. Gasser. 1993. Regulation of topoisomerase II by phosphorylation: a role for casein kinase II. J. Cell Sci. 104:219-225.
10. D'Arpa, P., and L.F. Liu. 1995. Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase I. Exp. Cell Res. 217:125-131.
11. Drake, F.H., G.A. Hofmann, H.F. Bartus, M.R. Mattern, S.T. Crooke, and C.K. Mirabelli. 1989. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry. 28:8154-8160.
12. Earnshaw, W., and M. Heck. 1985. Localization of topoisomerase II in mitotic chromosomes. J. Cell Biol. 100:1716-1725.
13. Earnshaw, W.C., and A.M. Mackay. 1994. Role of nonhistone proteins in the chromosomal events of mitosis. FASEB (Fed. Am. Soc. Exp. Biol.) J. 8:947-956.
14. Earnshaw, W., B. Halligan, C. Cooke, M. Heck, and L. Liu. 1985. Topoisomerase II is a structural component of mitotic chromosome scaffold. J. Cell Biol. 100:1706-1715.
15. Estey, E., R. Adlakha, W. Hittelman, and L. Zwelling. 1987. Cell cycle stage dependent variations in drug-induced lopoisomerase II-mediated DNA-cleavage and cytotoxicity. Biochemistry. 26:4438-4344.
16. Froelich-Ammon, S., and N. Osheroff. 1995. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270:21429-21432.
17. Goswami, P., J.L. Roti Roti, and C. Hunt. 1996. The cell cycle-coupled expression of topoisomerase II-alpha during S-phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol. Cell. Biol. 16:1500-1508.
18. Gremova, II, B. Thomsen, and S.V. Razin. 1995. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei, Proc. Natl. Acad. Sci. USA. 92:102-106.
19. Oupta, M., A. Fujimori, and Y. Pommier. 1995. Eukaryotic DNA topoisomerases I. Biochim. Biophys. Acta. 1262:1-14.
20. Hirano, T., and T.J. Mitchison. 1993. Topoisomerase II does not play a scaffolding role in the organization of mitotic chromosomes assembled in Xenopus egg extracts. J. Cell Biol. 120:601-612.
21. Hirano, T., G. Konoha, T. Toda, and M. Yanagida. 1989. Essential role of the RNA polymerase I largest subunit and DNA topoisomerases in the formation of fission yeast nucleolus. J. Cell Biol. 108:243-253.
22. Hoehstrasser, M. 1996. Protein degradation or regulation: Ub the judge. Cell. 84:813-815.
23. Hofmann, G.A., C.K. Mirabelli, and F.H. Drake. 1990. Quantitative adaptation of the bacteriophage P4 DNA unknolting assay for use in the biochemical and pharmacological characterization of topoisomerase II. Anticancer Res. 5:273-282.
24. Jenkins, J.R., P. Ayton, T. Jones, S.L. Davies, D.L. Simmons, A.L. Harris, D. Sheer, and I.D. Hickson. 1992. Isolation of cDN A clones encoding the beta isozyme of human DNA topoisomerase II and localization of the gene to chromosome 3p24. Nucleic Acids Res. 20:5587-5592.
25. Kimura, K., M. Saijo, M. Ui, and T. Enomoto. 1994. Growth state and cell cycle-dependent fluctuation in the expression of two forms of DNA lopoisomerase II and possible specific modification of the higher molecular weight form in the M phase. J. Biol. Chem. 269:1173-1176.
26. Kimura, K., N. Nozaki, T. Enomoto, M. Tanaka, and A. Kikuchi. 1996. Analysis of M phase specific phosphorylatiun of DNA topoisomerase II. J. Biol. Chem. 271:21439-21445.
27. Kingma, P.S., A.H. Corbett, P.C. Burcham, L.J. Marnett. and N. Osheroff. 1995. Abasic sites stimulate topoisomerase II-mediated DNA-cleavage: anticancer drugs mimic DNA-lesions. J. Biol. Chem. 270:21441-21444.
28. Kreipe, H., H.J. Heidebrecht, S. Hansen, W. Rohlk, M. Kubbies, H.H. Wacker, M. Tiemann, H.J. Radzun, and R. Parwaresch. 1993. A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Am. J. Pathol. 142:3-9.
29. Kretzschmar, M., M. Meisterernst, and R. Roeder. 1993. Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. Proc. Natl. Acad. Sci. USA. 90:11508-11512.
30. Lange, B.H.M., and K. Gull. 1996. Structure and function of the centriole in animal cells: progress and questions. Trends Cell Biol. 6:348-352.
31. Leteurtre, F., G. Kohlhagen, M.R. Fesen, A. Tanizawa, K.W. Kohn, and Y. Pommier. 1994. Effects of DNA methylation on topoisomerase I and II cleavage activities. J. Biol. Chem. 269:7893-7900.
32. Lim, M., L.F. Liu, K.D. Jacobson, and J.R. Williams. 1986. Induction of sister chromatid exchanges by inhibitors of topoisomerases. Cell Biol. Toxicol. 2:485-494.
33. Maul, G.G., B.T. French, W.J. van Venrooij, and S.A. Jimenez. 1986. Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase. Proc. Natl. Acad. Sci. USA. 83:5145-5149.
34. Muller, M.T., W.P. Pfund, V.B. Mehta, and D.K. Trask. 1985. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA, EMBO (Eur. Mol. Biol. Organ.) J. 4:1237-1243.
35. Murray, A. 1995. Cyclin ubiquitination: the destructive end of mitosis. Cell. 81:149-152.
36. Negri, C., R. Chiesa, A. Cerino, M. Bestagno, C. Sala, N. Zini, N.M. Maraldi, and R.G. Astaldi. 1992. Monoclonal antibodies to human DNA topoisomerase I and the two isoforms of DNA topoisomerase II: 170- and 180-kDa isozymes. Exp. Cell Res. 200:452-459.
37. Nitiss, J.L. 1994. Roles of DNA topoisomerases in chromosomal replication and segregation. Adv. Pharmacol. 29:103-134.
38. Oddou, P., U. Schmidt, R. Knippers, and A. Richter. 1988. Monoclonal antibodies neutralizing mammalian DNA topoisomerase I activity. Eur. J. Biochem. 177:523-529.
39. Osheroff, N. 1989. Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol. Ther. 41:223-241.
40. Osheroff, N., E.L. Zechiedrich, and K.C. Gale. 1991. Catalytic function of DNA topoisomerase II. Bioessays. 13:269-273.
41. Palazzo, R.E., E. Vaisberg, R.W. Cole, and C.L. Rieder. 1992. Centriole duplication in lysates of Spisula solidissima oocytes. Science (Wash. DC). 256:219-221.
42. Petrov, P., F.H. Drake, A. Loranger, W. Huang, and R. Hancock. 1993. Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy. Exp. Cell Res. 204:73-81.
43. Pinkel, D., J. Landegent, C. Collins, J. Fuscoe, R. Segraves, J. Lucas, and J. Gray. 1988. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc. Natl. Acad. Sci. USA. 85:9138-9142.
44. Poljak, L., and E. Kaes. 1995. Resolving the role of topoisomerase II in chromatin structure and function. Trends Cell Biol. 5:348-354.
45. Rattner, J.B., M.J. Hendzel, C.S. Furbee, M.T. Muller, and D.P. Bazett-Jones. 1996. Topoisomerase IIα is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure. J. Cell Biol. 134:1097-1107.
46. Rossi, F., E. Labourier, T. Forné, G. Divita, J. Derancourt, J. Riou, E. Antoine, G. Cathala, C. Brunel, and J. Tazi. 1996. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature (Lond.). 381:80-82.
47. Saijo, M., M. Ui, and T. Enomoto. 1992. Growth state and cell cycle dependent phosphorylation of DNA topoisomerase II in Swiss 3T3 cells. Biochemistry. 31:359-363.
48. Saitoh, Y., and U.K. Laemmli. 1994. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell. 76:609-622.
49. Sampson, S.A., H. Kreipe, C.E. Gillett, P. Smith, M.A. Chaudary, A. Khan, K. Wicks, R. Parwaresch, and D.M. Barnes. 1992. KiS1 - a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma. J. Pathol. 168:179-185.
50. Shuman, S. 1991. Recombination mediated by vaccinia virus DNA topoisomerase I in Escherichia coli is sequence specific. Proc. Natl. Acad. Sci. USA. 88:10104-10108.
51. Stevnsner, T., and V.A. Bohr. 1993. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair. Carcinogenesis (Lond.). 14:1841-1850.
52. Swedlow, J.R., J.W. Sedat, and D.A. Agard. 1993. Multiple chromosomal populations of topoisomcrase II detected in vivo by time-lapse, three-dimensional wide-field microscopy. Cell. 73:97-108.
53. Taagepera, S., P.N. Rao, F.H. Drake, and G.J. Gorbsky. 1993. DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc. Natl Acad. Sci. USA. 90:8407-8411.
54. Takano, H., K. Kohno, M. Ono, Y. Uchida, and M. Kuwano. 1991. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells. Cancer Res. 51:3951-3957.
55. Tricoli, J., B. Sahai, P. McCormick, S. Sarlinski, J. Berttam, and D. Kowalski. 1985. DNA topoisomerase I and II activities during cell proliferation and the cell cycle in cultured mouse embryo fibroblasts. Exp. Cell Res. 158:1-14.
56. Tsai-Pflugfelder, M., L.F. Liu, A.A. Liu, K.M. Tewey, W.-P.J., Tl Knutsen, K. Huebner, C.M. Croce, and J.C. Wang. 1988. Cloning and sequencing of cDNA encoding human DNA topoisomerase It and localization of the gene to chromosome region 17q21-22. Proc. Natl Acad. Sci. USA. 85:7177-7181.
57. Turley, H., M. Comley, S. Houlbrook, N. Nozaki, A. Kikuchi, I.D. Hickson, K. Gatter, and A.L. Harris. 1996. The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. Br. J. Cancer. In press.
58. Vassetzky, Y.S., Q. Dang, P. Benedetti, and S.M. Gasser. 1994. Topoisomerase II forms multimers in vitro: effects of metals, beta-glycerophosphate, and phosphorylation of its C-terminal domain. Mol. Cell. Biol. 14:6962-6974.
59. Wang, J.C. 1985. DNA topoisomerases. Annu. Rev. Biochem. 54:665-697.
60. Wang, J.C. 1987. DNA topoisomerases: from a laboratory curiosity to a subject in cancer chemotherapy. NCI (Natl. Cancer Inst.). Monogr. 1987:3-6.
61. Wang, J.C. 1987. Recent studies of DNA topoisomerases. Biochim. Biophys. Acta. 909:1-9.
62. Wang, J.C. 1991. DNA topoisomerases: why so many? J Biol. Chem. 266:6659-6662.
63. Withoff, S., W.N. Keith, A.J. Knol, J.C. Coutts, S.F. Hoare, N.H. Mulder, and E.G. deVries. 1996. Selection of a subpopulation with fewer DNA topoisomerase III alpha gene copies in a doxorubicin-resistani cell panel. Br. J. Cancer. 74:502-507.
64. Woessner, R.D., T.D. Chung, G.A. Hofmann, M.R. Mattern, C.K. Mirabelli, F.H. Drake, and R.K. Johnson. 1990. Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II. Cancer Res. 50:2901-2908.
65. Woessner, R.D., M.R. Mattern, C.K. Mirabelli, R.K. Johnson, and F.H. Drake. 1991. Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ. 2:209-214.
66. Wood, E.R., and W.C. Earnshaw. 1990. Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II. J. Cell Biol. 111:2839-2850.
67. Zhang, H., J.C. Wang, and L.F. Liu. 1988. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc. Natl. Acad. Sci. USA. 85:1060-1064.
68. Zini, N., A.M. Martelli, P. Sabatelli, S. Santi, C. Negri, R.G. Astaldi, and N.M. Maraldi. 1992. The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Exp. Cell Res. 200:460-466.
69. Zini, N., S. Santi, A. Ognibene, A. Bavelloni, L.M. Neri, A. Valmori, E. Mariani, C. Negri, G.C. Astaldi-Ricotti, and N.M. Maraldi. 1994. Discrete localisation of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions. Exp. Cell Res. 210:336-348.